213 related articles for article (PubMed ID: 15746104)
1. Mg2+ and Ca2+ differentially regulate DNA binding and dimerization of DREAM.
Osawa M; Dace A; Tong KI; Valiveti A; Ikura M; Ames JB
J Biol Chem; 2005 May; 280(18):18008-14. PubMed ID: 15746104
[TBL] [Abstract][Full Text] [Related]
2. Calcium-regulated DNA binding and oligomerization of the neuronal calcium-sensing protein, calsenilin/DREAM/KChIP3.
Osawa M; Tong KI; Lilliehook C; Wasco W; Buxbaum JD; Cheng HY; Penninger JM; Ikura M; Ames JB
J Biol Chem; 2001 Nov; 276(44):41005-13. PubMed ID: 11535596
[TBL] [Abstract][Full Text] [Related]
3. NMR structure of DREAM: Implications for Ca(2+)-dependent DNA binding and protein dimerization.
Lusin JD; Vanarotti M; Li C; Valiveti A; Ames JB
Biochemistry; 2008 Feb; 47(8):2252-64. PubMed ID: 18201103
[TBL] [Abstract][Full Text] [Related]
4. The metal-binding properties of DREAM: evidence for calcium-mediated changes in DREAM structure.
Craig TA; Benson LM; Venyaminov SY; Klimtchuk ES; Bajzer Z; Prendergast FG; Naylor S; Kumar R
J Biol Chem; 2002 Mar; 277(13):10955-66. PubMed ID: 11788589
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of Mg2+ and Ca2+ binding to CaBP1, a neuron-specific regulator of calcium channels.
Wingard JN; Chan J; Bosanac I; Haeseleer F; Palczewski K; Ikura M; Ames JB
J Biol Chem; 2005 Nov; 280(45):37461-70. PubMed ID: 16147998
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Photophysical, Thermodynamic, and Structural Properties of the Terbium(III)-DREAM Complex.
Gonzalez WG; Ramos V; Diaz M; Garabedian A; Molano-Arevalo JC; Fernandez-Lima F; Miksovska J
Biochemistry; 2016 Mar; 55(12):1873-86. PubMed ID: 26901070
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen-Deuterium Exchange Mass Spectrometry Reveals Calcium Binding Properties and Allosteric Regulation of Downstream Regulatory Element Antagonist Modulator (DREAM).
Zhang J; Li J; Craig TA; Kumar R; Gross ML
Biochemistry; 2017 Jul; 56(28):3523-3530. PubMed ID: 28627884
[TBL] [Abstract][Full Text] [Related]
8. DREAM is a Ca2+-regulated transcriptional repressor.
Carrión AM; Link WA; Ledo F; Mellström B; Naranjo JR
Nature; 1999 Mar; 398(6722):80-4. PubMed ID: 10078534
[TBL] [Abstract][Full Text] [Related]
9. The potassium channel interacting protein 3 (DREAM/KChIP3) heterodimerizes with and regulates calmodulin function.
Ramachandran PL; Craig TA; Atanasova EA; Cui G; Owen BA; Bergen HR; Mer G; Kumar R
J Biol Chem; 2012 Nov; 287(47):39439-48. PubMed ID: 23019329
[TBL] [Abstract][Full Text] [Related]
10. Effects of Ca2+, Mg2+, and myristoylation on guanylyl cyclase activating protein 1 structure and stability.
Lim S; Peshenko I; Dizhoor A; Ames JB
Biochemistry; 2009 Feb; 48(5):850-62. PubMed ID: 19143494
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the C-terminal half of human juvenile myoclonic epilepsy protein EFHC1: dimer formation blocks Ca2+ and Mg2+ binding to its functional EF-hand.
Murai MJ; Sassonia RC; Zamboni AH; Conte FF; Martins-de-Souza D; Aparicio R; de Oliveira MG; Lopes-Cendes I
Arch Biochem Biophys; 2008 Sep; 477(1):131-8. PubMed ID: 18593566
[TBL] [Abstract][Full Text] [Related]
12. The DREAM-DRE interaction: key nucleotides and dominant negative mutants.
Ledo F; Link WA; Carrión AM; Echeverria V; Mellström B; Naranjo JR
Biochim Biophys Acta; 2000 Dec; 1498(2-3):162-8. PubMed ID: 11108959
[TBL] [Abstract][Full Text] [Related]
13. Ca2+ and Mg2+ modulate conformational dynamics and stability of downstream regulatory element antagonist modulator.
Pham K; Dhulipala G; Gonzalez WG; Gerstman BS; Regmi C; Chapagain PP; Miksovska J
Protein Sci; 2015 May; 24(5):741-51. PubMed ID: 25627705
[TBL] [Abstract][Full Text] [Related]
14. Application of ANS fluorescent probes to identify hydrophobic sites on the surface of DREAM.
Gonzalez WG; Miksovska J
Biochim Biophys Acta; 2014 Sep; 1844(9):1472-80. PubMed ID: 24854592
[TBL] [Abstract][Full Text] [Related]
15. Ion-binding properties of Calnuc, Ca2+ versus Mg2+--Calnuc adopts additional and unusual Ca2+-binding sites upon interaction with G-protein.
Kanuru M; Samuel JJ; Balivada LM; Aradhyam GK
FEBS J; 2009 May; 276(9):2529-46. PubMed ID: 19302560
[TBL] [Abstract][Full Text] [Related]
16. Pb
Azam S; Miksovska J
ACS Chem Neurosci; 2019 Mar; 10(3):1263-1272. PubMed ID: 30399317
[TBL] [Abstract][Full Text] [Related]
17. Characterization of tescalcin, a novel EF-hand protein with a single Ca2+-binding site: metal-binding properties, localization in tissues and cells, and effect on calcineurin.
Gutierrez-Ford C; Levay K; Gomes AV; Perera EM; Som T; Kim YM; Benovic JL; Berkovitz GD; Slepak VZ
Biochemistry; 2003 Dec; 42(49):14553-65. PubMed ID: 14661968
[TBL] [Abstract][Full Text] [Related]
18. Solution structure and calcium-binding properties of EF-hands 3 and 4 of calsenilin.
Yu L; Sun C; Mendoza R; Wang J; Matayoshi ED; Hebert E; Pereda-Lopez A; Hajduk PJ; Olejniczak ET
Protein Sci; 2007 Nov; 16(11):2502-9. PubMed ID: 17962406
[TBL] [Abstract][Full Text] [Related]
19. Pro-apoptotic function of calsenilin/DREAM/KChIP3.
Jo DG; Kim MJ; Choi YH; Kim IK; Song YH; Woo HN; Chung CW; Jung YK
FASEB J; 2001 Mar; 15(3):589-91. PubMed ID: 11259376
[TBL] [Abstract][Full Text] [Related]
20. Functional implication with the metal-binding properties of KChIP1.
Chang LS; Chen CY; Wu TT
Biochem Biophys Res Commun; 2003 Nov; 311(2):258-63. PubMed ID: 14592407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
